Akumu, Atieno Jenipher

Contact Information

Email:	mailto:aakumu@umm.edu
Fax:

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

No closed protocols.

Publications

Publication Name	PubMed ID	Journal
A panel of sputum-based genomic marker for early detection of lung cancer.	20864512	Cancer Prev Res (Phila)
A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer.	28376184	J. Natl. Cancer Inst.
Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer.	20142235	Cancer Epidemiol. Biomarkers Prev.
Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.	19276181	Mol. Cancer Res.
ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.	20010854	Lab. Invest.
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.	19446359	Lung Cancer
Amplified RPS6KB1 and CDC2 genes are potential biomarkers for aggressive HIV+/EBV+ diffuse large B-cell lymphomas.	23330000	Int J Clin Exp Pathol
An unsupervised approach to identify molecular phenotypic components influencing breast cancer features.	14996713	Cancer Res.
Analysis of Lung Flute-collected Sputum for Lung Cancer Diagnosis.	26309391	Biomark Insights
Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis.	24305007	J Thorac Oncol
Analysis of small nucleolar RNAs in sputum for lung cancer diagnosis.	26246471	Oncotarget
C-MYC rearrangements are frequent in aggressive mature B-Cell lymphoma with atypical morphology.	18784824	Int J Clin Exp Pathol
Characterization of microRNA transcriptome in lung cancer by next-generation deep sequencing.	24785186	Mol Oncol
Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer.	19181417	Lung Cancer
Detecting genomic aberrations by fluorescence in situ hybridization with quantum dots-labeled probes.	18283800	J Nanosci Nanotechnol
Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.	26146958	Lab. Invest.
Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer.	23474761	Oncogene
Evaluation of lung flute in sputum samples for molecular analysis of lung cancer.	24053570	Clin Transl Med
Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.	17255269	Clin. Cancer Res.
Genome-wide small nucleolar RNA expression analysis of lung cancer by next-generation deep sequencing.	25159866	Int. J. Cancer
Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.	16369491	Oncogene
Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis.	18484646	Cancer
MicroRNAs as potential biomarkers in human solid tumors.	23196059	Cancer Lett.
Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.	19223503	Clin. Cancer Res.
Relation between normal rectal methylation, smoking status, and the presence or absence of colorectal adenomas.	20572039	Cancer
Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules.	25593345	Clin. Cancer Res.
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group.	19072545	J. Proteome Res.
Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target.	17699796	Cancer Res.

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.